Contact PD/PI: Blazar, Bruce A. Overall: Abstract. The University of Minnesota's Clinical and Translational Science Institute's (UMN CTSI) vision is a world where impactful discoveries leading to the betterment of human health occur by bringing together Academic Health Center (AHC) research with community outreach and industry partnership. Our mission is to create a nationally-recognized, shareable model of complex translational team science driven and enabled by integration and alignment of clinical and translational science (CTS) research with education, data access, community needs, and industry efforts. In the past 6 years, CTSI 1) Developed comprehensive programs for workforce training and fostering career development for the next generation of CTS research investigators; 2) Created Community Engagement to Advance Research and Community Health (CEARCH) to support stakeholder community contributions to CTS research and to tackle health outcome disparity challenges in Somali, Latino, Native American, Hmong, and other populations; 3) Leveraged UMN research strengths and MN's vibrant biomedical industry to advance multiple projects along the commercialization pathway; and 4) Expanded its patient base from the UMN tertiary care adult and pediatric hospitals to hub partners consisting of a VA hospital, a community-based 7-hospital system, and a safety-net county hospital with 65% racial/ethnic minorities linked with i2b2/SHRINE for cohort identification. CTSI formed an unprecedented partnership with Mayo CTSA to provide statewide coverage in CTS research and education and is a founding member of the Midwest Area Research Consortium for Health, the Accrual to Clinical Trials federated cohort discovery consortium, and PCORnet Greater Plains Collaborative. To accelerate and improve CTS research and education and make lasting impacts on healthcare outcomes, we will pursue the following aims: 1. Train an outstanding multidisciplinary, diverse workforce across the CTS research spectrum skilled in and rewarded for team science using existing and new educational offerings; 2. Streamline methods and processes to increase local and national CTSI hub research capacity in a new Clinics and Surgery Center learning health system with CTSI-led research process design, CTSI's new StudyFinder tool, user-friendly IRB-approved consent form for clinical and laboratory research, bioinfor- matics tools, biospecimen collection, and a transformative Clinical Research Support Center for one-stop, single location, parallel processing of needed approvals; 3. Engage communities and stakeholders through CEARCH to improve translation and healthcare delivery across the lifespan and to a diverse population; and 4. Add unique contributions to the CTSA network by the Office of Discovery and Translation , Pediatric Device Innovation Consortium, and high and ultrahigh magnetic resonance imaging and spectroscopy applications and training. Impact. Connected to and driven by its vision and mission, CTSI will provide infrastructure and services for conducting innovative, high-impact and efficient, high-quality CTS research. Project Summary/Abstract Page 391 Contact PD/PI: Blazar, Bruce

Public Health Relevance

The University of Minnesota's Clinical and Translational Science Institute (UMN CTSI) aims to create a nationally-recognized, shareable model of complex clinical and translational team science (CTS) driven by integration and alignment of CTS research with education, data access, and community and industry partnership. In pursuit of this aim and widespread health improvement, the CTSI will develop new CTS technologies and training programs, ensure CTS research of the highest quality and ethical standards, prepare investigators to be successful as the next generation of national CTS leaders, and create opportunities for CTS researchers to directly involve community members in all stages of their research. The CTSI will also focus on reducing health disparities by bringing clinical research to local underserved populations, advancing research to successful commercialization, and sharing unique UMN assets with the national consortium. Project Narrative Page 392

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR002494-04
Application #
10109162
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Zhang, Xinzhi
Project Start
2018-03-30
Project End
2023-02-28
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
4
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pediatrics
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Camchong, Jazmin; Cullen, Kathryn R; Lim, Kelvin O et al. (2018) Brain metabolism changes in women with BPD undergoing olanzapine treatment. Psychiatry Res Neuroimaging 279:19-21
Thammineni, Kalpana; Vinocur, Jeffrey M; Harvey, Brian et al. (2018) Outcomes after surgical coronary artery revascularisation in children with congenital heart disease. Heart 104:1417-1423
Glumac, Paige M; Forster, Colleen L; Zhou, Hong et al. (2018) The identification of a novel antibody for CD133 using human antibody phage display. Prostate 78:981-991
Spector, Logan G; Menk, Jeremiah S; Knight, Jessica H et al. (2018) Trends in Long-Term Mortality After Congenital Heart Surgery. J Am Coll Cardiol 71:2434-2446
Eder, Milton Mickey; Evans, Eunbyul; Funes, Melanie et al. (2018) Defining and Measuring Community Engagement and Community-Engaged Research: Clinical and Translational Science Institutional Practices. Prog Community Health Partnersh 12:145-156
Lock, Eric F; Li, Gen (2018) Supervised multiway factorization. Electron J Stat 12:1150-1180
Chow, Lisa S; Zmora, Rachel; Ma, Sisi et al. (2018) Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes. BMJ Open Diabetes Res Care 6:e000527
Migally, Karl; Braunlin, Elizabeth A; Zhang, Lei et al. (2018) Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease. Pediatr Res 83:1136-1145
Smith, Julia R; Hillman, Lisa; Drawz, Paul E (2018) Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients. Clin Exp Hypertens 40:569-573
Nestrasil, Igor; Ahmed, Alia; Utz, Josephine M et al. (2018) Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study. Mol Genet Metab 123:97-104

Showing the most recent 10 out of 167 publications